Physician Wealth Advisors’s Rentokil RTO Stock Holding History

Physician Wealth Advisors’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.29K	Hold	41	–	–	﹤0.01%	1543
2025 Q4	$1.21K	Buy	41 +13	+46%	+$361	﹤0.01%	1516
2025 Q3	$707	Hold	28	–	–	﹤0.01%	1729
2025 Q2	$672	Buy	+28	New	+$649	﹤0.01%	1625
2025 Q1	–	Sell	-24	Closed	-$608	–	1517
2024 Q4	$608	Buy	+24	New	+$608	﹤0.01%	1087

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return

Physician Wealth Advisors's RTO Position: Q1 2026 in Review

Physician Wealth Advisors held its Rentokil (RTO) position steady in Q1 2026 at 41 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

Physician Wealth Advisors first reported a position in RTO in Q4 2024 and has held it in 5 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

Physician Wealth Advisors held 41 shares of Rentokil worth $1.29K as of Q1 2026.
Physician Wealth Advisors left its Rentokil share count unchanged in Q1 2026.
Rentokil made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q1 2026, its #1543 holding.
Physician Wealth Advisors first reported a position in Rentokil in Q4 2024 and has held it in 5 quarters since.
282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.